COVID-19: A putative trigger for neuralgic amyotrophy

Affiliations

¹ Centre de Référence des Maladies Neuromusculaires AOC, FILNEMUS, Euro-NMD, Hôtel-Dieu, CHU Nantes, 44093 Nantes, France. Electronic address: gaelle.balloy@chu-nantes.fr.
² Centre de Référence des Maladies Neuromusculaires AOC, FILNEMUS, Euro-NMD, Hôtel-Dieu, CHU Nantes, 44093 Nantes, France.

Comment

G Balloy et al. Rev Neurol (Paris). 2022 Jan-Feb.

. 2022 Jan-Feb;178(1-2):157-158.

doi: 10.1016/j.neurol.2021.11.004. Epub 2021 Dec 23.

¹ Centre de Référence des Maladies Neuromusculaires AOC, FILNEMUS, Euro-NMD, Hôtel-Dieu, CHU Nantes, 44093 Nantes, France. Electronic address: gaelle.balloy@chu-nantes.fr.
² Centre de Référence des Maladies Neuromusculaires AOC, FILNEMUS, Euro-NMD, Hôtel-Dieu, CHU Nantes, 44093 Nantes, France.

No abstract available

Comment on

Variability of symptoms in neuralgic amyotrophy following infection with SARS-CoV-2.
Siepmann T, Kitzler HH, Reichmann H, Barlinn K. Siepmann T, et al. Muscle Nerve. 2021 Jan;63(1):E8-E9. doi: 10.1002/mus.27084. Epub 2020 Oct 14. Muscle Nerve. 2021. PMID: 33001444 Free PMC article.

1. Balcom E.F., Nath A., Power C. Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease. Brain J Neurol. 2021:awab302. - PMC - PubMed
1. Siepmann T., Kitzler H.H., Reichmann H., Barlinn K. Variability of symptoms in neuralgic amyotrophy following infection with SARS-CoV-2. Muscle Nerve. 2021;63(1):E8–E9. - PMC - PubMed
1. Mahajan S., Zhang F., Mahajan A., Zimnowodzki S. Parsonage Turner syndrome after COVID-19 vaccination. Muscle Nerve. 2021;64(1):E3–E4. - PMC - PubMed
1. Expert Panel on Neurologic Imaging. Bykowski J., Aulino J.M., Berger K.L., Cassidy R.C., Choudhri A.F., et al. ACR Appropriateness Criteria® Plexopathy. J Am Coll Radiol JACR. 2017;14(5S):S225–S233. - PubMed
1. Van Alfen N. Diagnosing neuralgic amyotrophy: choosing the right test at the right time. Muscle Nerve. 2017;56(6):1020–1021. - PubMed